Impact of new chemotherapy regimens on the treatment landscape and survival of advanced pancreatic cancer (PAC) patients (pts).

被引:1
|
作者
Kieler, Markus [1 ]
Unseld, Matthias [1 ]
Bianconi, Daniela [1 ]
Scheithauer, Werner [1 ]
Prager, Gerald W. [1 ]
机构
[1] Med Univ Vienna, Vienna, Austria
关键词
D O I
10.1200/JCO.2019.37.4_suppl.403
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
403
引用
收藏
页数:1
相关论文
共 50 条
  • [21] Evolving treatment landscape for early and advanced pancreatic cancer
    Lau, Sally C.
    Cheung, Winson Y.
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2017, 9 (07) : 281 - 292
  • [22] Prognostic model for survival in patients with advanced pancreatic cancer receiving palliative chemotherapy.
    Uneno, Yu
    Kou, Tadayuki
    Kanai, Masashi
    Yamamoto, Michio
    Xue, Peng
    Mori, Yukiko
    Kudo, Yasushi
    Kurita, Akira
    Uza, Norimitsu
    Kodama, Yuzo
    Asada, Masanori
    Masui, Toshihiko
    Yazumi, Shujiro
    Matsumoto, Shigemi
    Takaori, Kyoichi
    Morita, Satoshi
    Muto, Manabu
    Chiba, Tsutomu
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
  • [23] Evolving treatment landscape for early and advanced pancreatic cancer
    Sally C Lau
    Winson Y Cheung
    World Journal of Gastrointestinal Oncology, 2017, (07) : 281 - 292
  • [24] Survival benefits of adjuvant chemotherapy after conversion surgery in patients with advanced pancreatic cancer
    Lee, Yoon Suk
    Lee, Jang Won
    Kim, Hak Jun
    Chun, Jung Won
    Lee, Jong-Chan
    Jang, Dong Kee
    Hwang, Jin-Hyeok
    Kim, Young Ae
    Woo, Sang Myung
    FRONTIERS IN ONCOLOGY, 2025, 14
  • [25] Impact of Treatment Sequencing on Survival for Patients with Advanced Gastric Cancer
    Li, Selena S.
    Mullen, John T.
    Costantino, Christina L.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2019, 229 (04) : S265 - S266
  • [26] Heparin addition to chemotherapy improves survival in advanced pancreatic cancer
    Nature Clinical Practice Oncology, 2007, 4 (4): : 211 - 211
  • [27] The Impact of Treatment Effect on Survival is Different in Patients With Pancreatic Cancer Who Receive Neoadjuvant Chemotherapy Versus Chemoradiotherapy
    Maeda, S.
    Chawla, A.
    Yin, L.
    Burkhart, R. A.
    Burns, W. R.
    He, J.
    Cameron, J. L.
    Park, E. J.
    Girgis, M. D.
    Wainberg, Z. A.
    Hines, O. J.
    Fernandez-del Castillo, C.
    Qadan, M.
    Lillemoe, K. D.
    Ferrone, C. R.
    Wolfgang, C. L.
    Yu, J.
    Donahue, T. R.
    PANCREAS, 2019, 48 (10) : 1484 - 1484
  • [28] Immune checkpoint inhibitors combined with chemotherapy for the treatment of advanced pancreatic cancer patients
    Junxun Ma
    Danyang Sun
    Jinliang Wang
    Chun Han
    Yuanyu Qian
    Guangying Chen
    Xiaoyan Li
    Juan Zhang
    Pengfei Cui
    Wushuang Du
    Zhaozhen Wu
    Shixue Chen
    Xuan Zheng
    Zhichao Yue
    Jia Song
    Chan Gao
    Shangli Cai
    Yi Hu
    Cancer Immunology, Immunotherapy, 2020, 69 : 365 - 372
  • [29] Conditional Survival in Patients with Advanced Pancreatic Cancer
    Kasenda, Benjamin
    Bass, Annatina
    Koeberle, Dieter
    Pestalozzi, Bernhard
    Borner, Markus
    Herrmann, Richard
    Jost, Lorenz
    Lohri, Andreas
    Hess, Viviane
    JOURNAL OF THE PANCREAS, 2016, 17 (01): : 60 - 65
  • [30] Immune checkpoint inhibitors combined with chemotherapy for the treatment of advanced pancreatic cancer patients
    Ma, Junxun
    Sun, Danyang
    Wang, Jinliang
    Han, Chun
    Qian, Yuanyu
    Chen, Guangying
    Li, Xiaoyan
    Zhang, Juan
    Cui, Pengfei
    Du, Wushuang
    Wu, Zhaozhen
    Chen, Shixue
    Zheng, Xuan
    Yue, Zhichao
    Song, Jia
    Gao, Chan
    Cai, Shangli
    Hu, Yi
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2020, 69 (03) : 365 - 372